Senate Committee Investigates Ozempic and Wegovy Costs - NYT
Tweet
Share
E-mail
Get Alerts NVO Hot Sheet
Join SI Premium – FREE
(Updated - April 24, 2024 12:04 PM EDT)
Senate Committee Investigates Ozempic and Wegovy Costs - NYT
- Senator Bernie Sanders is pressing Novo Nordisk (NYSE: NVO) for details on its pricing of the popular diabetes and weight loss medications.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Novo Nordisk (NVO) Capital Markets Day preview
- Novo Resources Releases Updated Corporate Presentation
- AppLovin (APP) on watch amid 3% drop premarket as boutique comments circulate
Create E-mail Alert Related Categories
Politics, Trader TalkSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
